WallStreetZenWallStreetZen

Sectors & IndustriesConsumer DefensivePharmaceutical Retailers
Best Pharmaceutical Retailer Stocks to Buy Now (2023)
Top pharmaceutical retailer stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

Industry: Pharmaceutical Retailers
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
LFLY
LEAFLY HOLDINGS INC
United States
$24.02M40,035,56816.52%26.17%Net SellingNet Selling
PETS
PETMED EXPRESS INC
United States
$453.55M21,075,67751.82%48.18%Net Buying
GNLN
GREENLANE HOLDINGS INC
United States
$6.94M15,951,5014.53%95.47%Net SellingNet Selling
HITI
HIGH TIDE INC
Canada (Federal Level)
$115.74M68,080,5301.80%0.00%
WBA
WALGREENS BOOTS ALLIANCE INC
United States
$32.06B862,503,55431.30%68.70%Net SellingNet Selling
YI
111 INC
China
$257.57M166,710,9071.98%0.00%
MEDS
TRXADE HEALTH INC
United States
$4.17M9,318,7083.74%96.26%Net Buying
BIMI
BIMI INTERNATIONAL MEDICAL INC
China
$5.50M3,843,4760.34%99.66%Net Buying
LFMD
LIFEMD INC
United States
$61.01M31,449,73517.01%48.34%Net Buying
RAD
RITE AID CORP
United States
$202.92M56,523,35423.20%76.80%Net Selling

Pharmaceutical Retailer Stocks FAQ

What are the best pharmaceutical retailer stocks to buy right now in Jan 2023?

According to Zen Score, the 3 best drug store stocks to buy right now are:

1. Leafly Holdings (NASDAQ:LFLY)


Leafly Holdings (NASDAQ:LFLY) is the top pharmaceutical retailer stock with a Zen Score of 50, which is 23 points higher than the pharmaceutical retailer industry average of 27. It passed 16 out of 33 due diligence checks and has strong fundamentals. Leafly Holdings has seen its stock lose -91.61% over the past year, underperforming other pharmaceutical retailer stocks by -44 percentage points.

Leafly Holdings has an average 1 year price target of $4.00, an upside of 566.67% from Leafly Holdings's current stock price of $0.60.

Leafly Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Leafly Holdings, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Petmed Express (NASDAQ:PETS)


Petmed Express (NASDAQ:PETS) is the second best pharmaceutical retailer stock with a Zen Score of 42, which is 15 points higher than the pharmaceutical retailer industry average of 27. It passed 14 out of 38 due diligence checks and has strong fundamentals. Petmed Express has seen its stock lose -16% over the past year, overperforming other pharmaceutical retailer stocks by 31 percentage points.

Petmed Express has an average 1 year price target of $18.00, a downside of -16.36% from Petmed Express's current stock price of $21.52.

Petmed Express stock has a consensus Strong Sell recommendation according to Wall Street analysts. Of the 1 analyst covering Petmed Express, 0% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 100% have issued a Strong Sell.

3. Greenlane Holdings (NASDAQ:GNLN)


Greenlane Holdings (NASDAQ:GNLN) is the third best pharmaceutical retailer stock with a Zen Score of 38, which is 11 points higher than the pharmaceutical retailer industry average of 27. It passed 12 out of 33 due diligence checks and has average fundamentals. Greenlane Holdings has seen its stock lose -96.69% over the past year, underperforming other pharmaceutical retailer stocks by -49 percentage points.

Greenlane Holdings has an average 1 year price target of $1.38, an upside of 216.09% from Greenlane Holdings's current stock price of $0.44.

Greenlane Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Greenlane Holdings, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical retailer stocks with highest dividends?

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

1. Petmed Express (NASDAQ:PETS)


Petmed Express (NASDAQ:PETS) has an annual dividend yield of 5.58%, which is the same as the pharmaceutical retailer industry average of 5.36%. Petmed Express's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Petmed Express's dividend has shown consistent growth over the last 10 years.

Petmed Express's dividend payout ratio of 115.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Walgreens Boots Alliance (NASDAQ:WBA)


Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 5.15%, which is the same as the pharmaceutical retailer industry average of 5.36%. Walgreens Boots Alliance's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Walgreens Boots Alliance's dividend has shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -55.7% indicates that its high dividend yield might not be sustainable for the long-term.

Why are pharmaceutical retailer stocks up?

Pharmaceutical retailer stocks were up 1.67% in the last day, and up 7.08% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are up.

What are the most undervalued pharmaceutical retailer stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

1. Leafly Holdings (NASDAQ:LFLY)


Leafly Holdings (NASDAQ:LFLY) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Leafly Holdings has a valuation score of 86, which is 54 points higher than the pharmaceutical retailer industry average of 32. It passed 6 out of 7 valuation due diligence checks.

Leafly Holdings's stock has dropped -91.61% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -44 percentage points.

2. Greenlane Holdings (NASDAQ:GNLN)


Greenlane Holdings (NASDAQ:GNLN) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Greenlane Holdings has a valuation score of 43, which is 11 points higher than the pharmaceutical retailer industry average of 32. It passed 3 out of 7 valuation due diligence checks.

Greenlane Holdings's stock has dropped -96.69% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -49 percentage points.

3. Bimi International Medical (NASDAQ:BIMI)


Bimi International Medical (NASDAQ:BIMI) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Bimi International Medical has a valuation score of 43, which is 11 points higher than the pharmaceutical retailer industry average of 32. It passed 3 out of 7 valuation due diligence checks.

Bimi International Medical's stock has dropped -92.42% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -45 percentage points.

Are pharmaceutical retailer stocks a good buy now?

33.33% of pharmaceutical retailer stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical retailer stocks to rise by 42.91% over the next year.

What is the average p/e ratio of the pharmaceutical retailers industry?

The average P/E ratio of the pharmaceutical retailers industry is -10.08x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.